Tata Steel faces a hefty Rs 1,755 crore mining claim, potentially impacting its finances significantly. Meanwhile, Emami is set to acquire a substantial 73.5% stake in Axiom Ayurveda, and Shree Cement plans to invest Rs 1,800 crore in a new plant in Meghalaya.

ICICI Securities advises purchasing Tata Steel shares at around ₹189-195, with a projected target of ₹216 and a stop loss of ₹179. Last week, despite global volatility, IT, Metals, and Defense stocks saw gains, while Pharma and Financial sectors experienced profit booking, leading to a 0.5% decline in the Nifty 50 index.

Tata Steel has received a demand of approximately ₹1,755 crore due to alleged overmining of coal at West Bokaro Colliery dating back to FY 2000-07. The company plans to contest the issue legally.

Tata Steel and Jindal Steel could see a boost in their Q4 earnings this fiscal year due to increased domestic prices, reduced imports, and robust demand. However, potential issues with LNG supply may impact JSW Steel's spreads.

Tata Steel receives an upgrade to 'Buy' by Anand Rathi, with a new target price set at Rs 240. This decision is based on the company's European operations approaching breakeven, increased domestic capacity (reaching 27.35MT), and a robust recovery in prices that enhances margins.

Investment advisor, Anand Rathi, encourages buying Tata Steel shares with the current price standing at ₹194.7.

Tata Steel has officially taken over Medica TS Hospital, making it a fully owned subsidiary of the company. The deal involved purchasing approximately 7.4 lakh equity shares and 2.3 crore OCRPS for a total cost of ₹1.49 crore.

Tata Steel has applied for approval to explore an iron ore block in Odisha, which requires the diversion of 216.9 hectares of forest land in Keonjhar. The center's approval is awaited for this forest land diversion, intended for Tata Steel's mining operations.